肝がん再発予測用ＤＮＡメチル化マーカー及びその用途

Title:

肝がん再発予測用ＤＮＡメチル化マーカー及びその用途

Document Type and Number:

Japanese Patent JP2022522354

Kind Code:

A

Abstract:

本発明は、肝がんの予後によってＤＮＡメチル化レベルが異なる点を用いた、肝がん再発予測用ＤＮＡメチル化マーカーに関し、前記マーカーを使用すると、肝がんの再発の有無を容易に予測でき、肝がん再発のリスクが高い患者により個人化された治療法を提供し、不必要な過剰治療を避けるための臨床情報を提供しうる。

More Like This:

WO/2017/214834	LENTIVIRAL EXPRESSION VECTOR FOR SPECIFICALLY PROMOTING HIGH EXPRESSION OF CTLA-4 GENE, AND APPLICATIONS THEREOF
WO/2016/164762	POLYNUCLEOTIDES ENCODING LOW DENSITY LIPOPROTEIN RECEPTOR EGF-A AND INTRACELLULAR DOMAIN MUTANTS AND METHODS OF USING THE SAME
WO/2012/000445	NEW PCR SEQUENCING METHOD AND USE THEREOF IN HLA GENOTYPING

Inventors:

Yong Jun Kim
Ta Won Kim
Tae Yu Kim
Kwan Won Lee
John Sill Ha

Application Number:

JP2021550256A

Publication Date:

April 18, 2022

Filing Date:

February 26, 2020

Export Citation:

Assignee:

Lepidin Company Limited

International Classes:

C12N15/11; C12Q1/68

Domestic Patent References:

JP2015006163A

2015-01-15

Foreign References:

Other References:

HEPATOLOGY, vol. 61, JPN7021002579, 2015, pages 1945 - 1956, ISSN: 0004999340

Attorney, Agent or Firm:

Murayama Yasuhiko
Shinya Mihiro
Tatsuhiko Abe

Previous Patent: Ultrasound method and equipment

Next Patent: Fusion system, instruments, bone plates and usage